Guide Therapeutics, Inc. — Form D
Guide Therapeutics, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-28. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-02-28
- Form: D
- Accession: 0001769132-19-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.5M
- Remaining: $2.5M
- Investors: 1
- Date of first sale: 2019-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-333816
Issuer
- Name: Guide Therapeutics, Inc.
- CIK: 0001769132
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 308 NORTHYARDS BLVD. Suite B, NW, ATLANTA, GA, 30013
- Phone: 404-937-3801
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| James Dahlman | Director | Atlanta, GA |
| James Dahlman | Executive Officer | Atlanta, GA |
| James Dahlman | Related Person | Atlanta, GA |
| Andrew Perlman | Director | Atlanta, GA |
| Andrew Perlman | Related Person | Atlanta, GA |
| Boris Nikolic | Related Person | Atlanta, GA |
| Julie Sunderland | Director | CAMBRIDGE, MA |
| Robert Hershberg | Director | Tucker, GA |
| Thomas Reese Saylor | Director | Atlanta, GA |
| Thomas Reese Saylor | Executive Officer | Atlanta, GA |
| Thomas Reese Saylor | Related Person | Atlanta, GA |
| James Reese Dahlman | Director | Atlanta, GA |
| Andrew Reese Perlman | Director | Atlanta, GA |
| Boris Reese Nikolic | Director | Atlanta, GA |
Other filings by this issuer (3)
More